Patents by Inventor Lenka Munoz

Lenka Munoz has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11939296
    Abstract: The present invention relates to new pharmaceutical agents, and to their use in the treatment of proliferative diseases, such as cancer (in particular, brain cancer).
    Type: Grant
    Filed: August 30, 2022
    Date of Patent: March 26, 2024
    Assignee: The University of Sydney
    Inventors: Michael Kassiou, William Jorgensen, Lenka Munoz
  • Publication number: 20230028660
    Abstract: The present invention relates to new pharmaceutical agents, and to their use in the treatment of proliferative diseases, such as cancer (in particular, brain cancer).
    Type: Application
    Filed: August 30, 2022
    Publication date: January 26, 2023
    Applicant: The University of Sydney
    Inventors: Michael KASSIOU, William JORGENSEN, Lenka MUNOZ
  • Patent number: 11472774
    Abstract: The present invention relates to new pharmaceutical agents, and to their use in the treatment of proliferative diseases, such as cancer (in particular, brain cancer). In some embodiments, the present invention relates to compounds of formula (I): or pharmaceutically acceptable salts or prodrugs thereof.
    Type: Grant
    Filed: February 1, 2019
    Date of Patent: October 18, 2022
    Assignee: THE UNIVERSITY OF SYDNEY
    Inventors: Michael Kassiou, William Jorgensen, Lenka Munoz
  • Publication number: 20210094915
    Abstract: The present invention relates to new pharmaceutical agents, and to their use in the treatment of proliferative diseases, such as cancer (in particular, brain cancer).
    Type: Application
    Filed: February 1, 2019
    Publication date: April 1, 2021
    Applicant: The University of Sydney
    Inventors: Michael KASSIOU, Wiiliam UORGENSEN, Lenka MUNOZ
  • Patent number: 10745355
    Abstract: The present invention relates to new pharmaceutical agents, and to their use in the treatment of proliferative diseases, such as cancer (in particular, brain cancer).
    Type: Grant
    Filed: January 29, 2016
    Date of Patent: August 18, 2020
    Assignee: THE UNIVERSITY OF SYDNEY
    Inventors: Lenka Munoz, Fadi Maged Shokry Gurgis, Mia Akerfeldt, Michael Kassiou
  • Publication number: 20180273478
    Abstract: The present invention relates to new pharmaceutical agents, and to their use in the treatment of proliferative diseases, such as cancer (in particular, brain cancer).
    Type: Application
    Filed: January 29, 2016
    Publication date: September 27, 2018
    Applicant: THE UNIVERSITY OF SYDNEY
    Inventors: Lenka Munoz, Fadi Maged Shokry Gurgis, Mia Akerfeldt, Michael Kassiou
  • Publication number: 20090318491
    Abstract: The present invention relates to compounds which are derivatives of cytisine or acetylcholine which exhibit activity as agonists, partial agonists or antagonists of nicotinic acetylcholine receptors and may be used in modulating these receptors and in treating mood disorders in patients in need of therapy.
    Type: Application
    Filed: January 26, 2007
    Publication date: December 24, 2009
    Applicants: Yale Univeristy, Reheinische Friedrich-Wilhelms- Univeristy Bonn
    Inventors: Marina Picciotto, Daniela Gundisch, Lenka Munoz, Matthias Andra, Yann Mineur